Twist Bioscience (TWST) Payables (2018 - 2026)

Twist Bioscience (TWST) has reported Payables for 9 consecutive years, with $14.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Payables rose 82.09% year-over-year to $14.7 million; the TTM figure through Mar 2026 stood at $14.7 million (up 82.09% YoY), while the FY2025 annual figure was $11.1 million, up 580.61% from the prior year.
• Payables grew to $14.7 million in Q1 2026 per TWST's latest filing, from $12.5 million in the prior quarter.
• Across five years, Payables topped out at $21.0 million in Q2 2022 and bottomed at $1.6 million in Q3 2024.
• Historically, Payables has averaged $12.2 million across 5 years, with a median of $12.1 million in 2023.
• Annual changes were most pronounced in 2023 — Payables tumbled 53.98% — and 2025, when it surged 580.61%.
• Twist Bioscience's Payables stood at $20.1 million in 2022, then sank by 53.98% to $9.3 million in 2023, then retreated by 18.94% to $7.5 million in 2024, then surged by 66.51% to $12.5 million in 2025, then advanced by 17.52% to $14.7 million in 2026.
• Business Quant data shows TWST's Payables at $14.7 million in Q1 2026, $12.5 million in Q4 2025, and $11.1 million in Q3 2025.